Vitamin D for the Treatment of Women With Polycystic Ovary Syndrome (PCOS)

• Status: Completed
• Trial end date: 2014-09-01
• Target enrollment: 0
• Participant gender: Female

Summary

The purpose of this study is to determine if vitamin D will improve insulin resistance, inflammation, and overall well-being in women with PCOS.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Milton S. Hershey Medical Center
• Treatments: Ergocalciferols; Vitamin D; Vitamins

Criteria

Inclusion Criteria:

• Diagnosis of PCOS based on:

• Eight or fewer menstrual periods per year or spontaneous intermenstrual periods of greater than or equal to 45 days, and

• Elevated testosterone levels

Exclusion Criteria:

• Current Pregnancy or Nursing

• Elevated calcium

• Kidney Stones or kidney disease

• Current use of vitamin D (other than a multivitamin)

• Use of metformin or other insulin sensitizing drugs in the last 3 months

• Elevated prolactin or untreated thyroid disease

• Diabetes, Liver disease, Heart disease, or other serious medical condition